References
- Chen J, Schooling CM, Johnston JM, Hedley AJ, McGhee SM. How does socioeconomic development affect COPD mortality? An age-period-cohort analysis from a recently transitioned population in China. PLoS ONE6(9), e24348 (2011).
- Tan WC, Ng TP. COPD in Asia: where east meets west. Chest133(2), 517–527 (2008).
- Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet364(9434), 613–620 (2004).
- Simon-Tuval T, Scharf SM, Maimon N, Bernhard-Scharf B, Reuveni H, Tarasiuk A. Determinants of elevated health care utilization in patients with COPD. Respir. Res.12(1), 7–15 (2011).
- Shaya FT, Du D, Akazawa M et al. Burden of concomitant asthma and COPD in a Medicaid population. Chest134(1), 14–19 (2008).
- Lin P, Shaya FT, Scharf SM. Economic implications of comorbid conditions among Medicaid beneficiaries with COPD. Respir. Med.104(5), 697–704 (2010).
- Shaya FT, Samant N, Pradel F, Mullins CD, Scharf S, Britt E. Health-related quality of life as a potential predictor in chronic obstructive lung disease patients. Expert Rev. Pharmacoeconomics Outcomes Res.7(2), 129–135 (2007).
Website
- GOLD Executive Committee. Global initiative for Chronic Obstructive Lung Disease: Global strategy for the diagnosis, management, and prevention of Chronic Obstructive Pulmonary Disease. www.goldcopd.org